These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluating the safety of diabetes drugs: perspective of a Food and Drug Administration insider. Misbin RI Diabetes Care; 2005 Oct; 28(10):2573-6. PubMed ID: 16186303 [No Abstract] [Full Text] [Related]
6. FDA approach to the regulation of drugs for diabetes. Fleming A Am Heart J; 1999 Nov; 138(5 Pt 1):S338-45. PubMed ID: 10539795 [No Abstract] [Full Text] [Related]
7. FDA considers data confidentiality for diabetes drugs. Traynor K Am J Health Syst Pharm; 2014 Oct; 71(19):1607-8. PubMed ID: 25225443 [No Abstract] [Full Text] [Related]
8. The UGDP and the FDA audit. Am Fam Physician; 1979 Jul; 20(1):67. PubMed ID: 377929 [No Abstract] [Full Text] [Related]
9. The FDA and hypoglycemic drugs. Davidson JK JAMA; 1975 May; 232(8):853-5. PubMed ID: 1091764 [No Abstract] [Full Text] [Related]
10. Controversy over study of diabetes drugs continues for nearly a decade. Kolata GB Science; 1979 Mar; 203(4384):986-90. PubMed ID: 370980 [No Abstract] [Full Text] [Related]
12. Cardiovascular safety and diabetes drug development. Drucker DJ; Goldfine AB Lancet; 2011 Mar; 377(9770):977-9. PubMed ID: 21316097 [No Abstract] [Full Text] [Related]
13. Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. Zannad F; Stough WG; Lipicky RJ; Tamargo J; Bakris GL; Borer JS; Alonso GarcĂa Mde L; Hadjadj S; Koenig W; Kupfer S; McCullough PA; Mosenzon O; Pocock S; Scheen AJ; Sourij H; Van der Schueren B; Stahre C; White WB; Calvo G Eur Heart J Cardiovasc Pharmacother; 2016 Jul; 2(3):200-5. PubMed ID: 27418973 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of diabetes mellitus with a mixture of oral hypoglycemic agents]. Quibrera R; Nava M; Grimaldo JI Gac Med Mex; 1979 Mar; 115(3):121-6. PubMed ID: 378748 [No Abstract] [Full Text] [Related]
15. The oral hypoglycemic controversy. Stay as sweet as you are. Gregory DR Leg Aspects Med Pract; 1979 Mar; 7(3):16-9. PubMed ID: 106193 [No Abstract] [Full Text] [Related]
16. What went wrong? A retrospective on Exubera. Baran MK; Godoy AT Adv Nurse Pract; 2008 Nov; 16(11):53-4, 77. PubMed ID: 19999057 [No Abstract] [Full Text] [Related]
18. New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA. Hussar DA; Kaczinski J J Am Pharm Assoc (2003); 2010; 50(3):436-9. PubMed ID: 20452924 [No Abstract] [Full Text] [Related]
19. Improving how we evaluate the toxicity of approved drugs. Reidenberg MM Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311 [No Abstract] [Full Text] [Related]
20. Statement on fixed ratio combinations of drugs. Moss JM Va Med Mon (1918); 1971 Sep; 98(9):472-3. PubMed ID: 5119159 [No Abstract] [Full Text] [Related] [Next] [New Search]